secwatch.observer — SEC 8-K summary
======================================

Issuer:     Doximity, Inc. (DOCS)
CIK:        0001516513
Form:       8-K
Filed at:   2022-02-08T23:59:59+00:00
Accession:  0001516513-22-000007
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Doximity Q3 revenue $97.9M (+67% YoY), net margin 57%, guides FY23 rev ~$450M
-----------------------------------------------------------------------------

- Revenue $97.9M (+67% YoY); net income $55.6M (57% margin); non-GAAP diluted EPS $0.29.
- Adjusted EBITDA $47.0M (+119% YoY); margin 48% vs 37% prior year.
- Q4 guidance: rev $89-90M, adj EBITDA $34-35M; FY23 prelim: rev ~$450M (33% growth excl. Amion), adj EBITDA margin ≥40%.
- Agreed to acquire Amion (powers ~200K physician schedules); CCO Joseph Kleine retires to advisor role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516513/000151651322000007/0001516513-22-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516513/000151651322000007/docs-20220208.htm
  HTML page:      https://secwatch.observer/filing/0001516513-22-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer